
Pumpkin seed oil for hair loss has promising but limited evidence. One 24-week randomized trial in 76 men found a 40% mean rise in hair count, versus 10% with placebo. A smaller three-month trial in 60 women found that topical oil improved several microscope-based signs. Minoxidil performed better on key measures. Neither study proves that any supermarket oil or supplement will regrow hair. Treat it as an optional adjunct, not a proven replacement.
What the 2014 study actually found
Cho and colleagues enrolled 76 men aged 20 to 65 with mild to moderate androgenetic alopecia at one South Korean hospital. They assigned 37 men to a branded oral capsule described as 400 mg of pumpkin seed oil daily. The other 39 received placebo for 24 weeks.
That amount describes the trial. It is not a dosing recommendation.
Hair counts rose by 30% in the capsule group and 5% with placebo at week 12. By week 24, the changes were 40% and 10%. The absolute changes were 6.2 versus 1.8 hairs in the magnified field used for counting. Hair thickness did not differ between groups.
The headline “40% increase” needs context. It was a mean percentage change in one measured scalp area, not 40% more coverage across the head. It also wasn't the share of men who improved. At week 24, a blinded assessor rated 17 of 37 treated men as slightly or moderately improved. Nineteen looked unchanged, and one looked worse.
The study had several safeguards: random assignment, placebo capsules, double blinding and standardized photographs. It also had material limits. Twelve men dropped out, and missing values were carried forward. The capsule supplier funded the study and held the randomization codes. The paper did not report a full ingredient specification or oil standardization, which makes exact replication with a retail product difficult.
What the topical study in women adds
Ibrahim and colleagues published a second randomized trial in the Journal of Cosmetic Dermatology in 2021. It enrolled 60 women aged 18 to 50 with mild or moderate female pattern hair loss. Thirty applied topical pumpkin seed oil, while 30 used 5% minoxidil foam. Both groups applied 1 mL once daily for three months.
The oil group improved on dermoscopic measures. Mean hair-shaft diversity fell from 30.5% to 24.0%, while the count of upright regrowing hairs rose from 0.13 to 0.9. Minoxidil produced a larger change in shaft diversity and more regrowing hairs. The authors judged minoxidil more effective.
This trial had no inactive oil vehicle or untreated group. Its report does not describe blinding. That design cannot separate all treatment effects from measurement variation or change over time. Three months is also short for hair research. The results apply to diagnosed female pattern loss, not every cause of shedding.
How strong is the evidence?
Drake and colleagues' 2023 JAMA Dermatology systematic review found a possible benefit from pumpkin seed oil. The reviewers still called for larger randomized trials with active comparisons. Adil and Godwin's 2017 meta-analysis found far broader trial support for minoxidil and finasteride in pattern hair loss.
Kanti and colleagues' 2018 European guideline reaches the same practical hierarchy. It places topical minoxidil and oral finasteride among standard options for suitable patients, with sex-specific cautions.
| Option | Best direct evidence | Reasonable conclusion | Main limit |
|---|---|---|---|
| Oral pumpkin seed oil in men | One 24-week placebo-controlled trial | A possible hair-count benefit | Small, single product, company-funded and not independently replicated |
| Topical pumpkin seed oil in women | One three-month comparison with minoxidil | A possible signal on dermoscopy | No inactive control; minoxidil did better on key outcomes |
| Topical minoxidil | Multiple randomized trials and meta-analysis | Better-supported for male and female pattern loss | Results vary and require continued use |
| Prescription finasteride for men | Multiple randomized trials and meta-analysis | Better-supported for male pattern loss | Needs a clinician discussion about suitability and adverse effects |
Pumpkin seed oil has not beaten placebo in women or faced minoxidil in men. No trial shows that adding it to a proven treatment improves results. Calling it equivalent to established care goes beyond the data.
How long could results take?
The men's trial detected a hair-count difference at 12 weeks, but self-ratings did not separate from placebo then. Those ratings differed at 24 weeks. The women's topical trial measured changes after three months.
So two or four weeks tells you little. The studied assessment window was about three to six months. Neither trial followed people after stopping, so we don't know whether any gain persists. They also don't show whether results keep improving beyond six months.
If you try an optional approach after a clinician or pharmacist checks it, use comparable photos at baseline, week 12 and week 24. Keep the light, angle, part, hair length and styling consistent. Photos can reveal a trend, but they cannot diagnose its cause.

Three claims that go beyond the studies
- “It blocks DHT.” The proposed 5-alpha-reductase effect comes from mechanism work. The men's trial did not measure DHT, and free testosterone did not change. A plausible mechanism is not proof of what happened.
- “It regrows 40% of lost hair.” The 40% figure was a group average within a measured field. It was not restored scalp coverage, and thickness did not beat placebo.
- “Pumpkin seeds, cooking oil and capsules are interchangeable.” Neither trial tested a serving of seeds. The oral paper did not fully specify or standardize the retail-comparable formula.
Side effects and gaps in safety data
No common adverse-effect rate can be estimated from these small, short studies. In the oral trial, one treated participant reported mild abdominal discomfort, and one reported whole-body itching. One placebo participant also reported itching. A study of 76 men cannot rule out uncommon harms or show long-term safety.
The topical trial excluded pregnancy, breastfeeding, known hypersensitivity, scalp disease and recent treatment. It provides no safety answer for those situations. Stop topical use if it causes burning, swelling or a rash. Check an oral supplement's full label with a pharmacist if you take medicines or have allergies.
Established options have trade-offs too. Topical minoxidil can irritate the scalp and may cause an early shedding phase. Prescription finasteride needs a clinician-led review of sexual and reproductive risks. Those risks are better described than pumpkin seed oil's long-term safety.
Match the treatment to the type of hair loss
Both trials studied pattern hair loss. They did not study sudden shedding after illness, postpartum shedding, low iron, traction, alopecia areata, scarring loss or hair-shaft breakage. Start by learning to tell shedding from breakage. Women with gradual central thinning can compare their signs with this guide to a widening part.
The American Academy of Dermatology says effective care starts by finding the cause. A scalp exam, history and sometimes blood tests or biopsy can change the treatment. Seek medical assessment before experimenting if loss is sudden, patchy, painful, inflamed, scaly or scar-like. Do the same if eyebrows or eyelashes are affected.
For confirmed pattern loss, compare the weaker oil evidence against established options. Women can review the evidence on 2% versus 5% minoxidil. Men can use the finasteride and dutasteride comparison to prepare questions for a clinician. If preserving hair is the priority, don't spend six months on oil alone without first confirming the diagnosis.

Oscar Nascimento
Editorial writer, GlowUp Face
Oscar writes about evidence-based skin care, healthcare, looksmaxxing, and the social and economic research surrounding appearance.
Full profile and all articles →





